AGP Executive Report
Last update: an hour agoLife Sciences & Health: Oxeia Biopharma added US Navy Rear Admiral Don Plummer to its advisory board as military concussion injuries keep spotlighting the lack of FDA-approved treatments. Biotech Pipeline: GENFIT reported positive Phase 1b results for GNS561 plus a MEK inhibitor in heavily pretreated KRAS-mutated cholangiocarcinoma, with Phase 2 on track for 2H26. Transplant Tech: Lungpacer presented DONATE study results in Boston showing temporary transvenous phrenic nerve stimulation can improve donor lung suitability and increase lungs allocated for transplant. Corporate Deals: AbbVie agreed to buy Apogee Therapeutics for $10.9B, aiming to expand immunology and anti-inflammatory options. Aviation Tech: The FAA is partnering with Boston-based Airspace Intelligence to deploy AI tools to reduce flight delays, targeting full operation by end of 2028. Local Innovation: Avancell leased 128,000 sq ft at IQHQ’s Innovation Park in Andover for future commercial cancer drug production. Policy: The Senate passed a bipartisan housing bill to curb large institutional purchases of single-family homes and boost new construction. Data Centers: Forty mayors signed a pact to shape sustainable urban data center growth.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
